Document is current
Any future updates will be listed below
-
Authors
Chen, Haiquan
Carrot-Zhang, Jian https://orcid.org/0000-0002-0103-9965
Zhao, Yue
Hu, Haichuan
Freeman, Samuel S.
Yu, Su
Ha, Gavin https://orcid.org/0000-0001-7578-7272
Taylor, Alison M.
Berger, Ashton C.
Westlake, Lindsay
Zheng, Yuanting
Zhang, Jiyang
Ramachandran, Aruna
Zheng, Qiang
Pan, Yunjian
Zheng, Difan
Zheng, Shanbo
Cheng, Chao
Kuang, Muyu
Zhou, Xiaoyan
Zhang, Yang
Li, Hang
Ye, Ting
Ma, Yuan
Gao, Zhendong
Tao, Xiaoting
Han, Han
Shang, Jun https://orcid.org/0000-0002-5767-1492
Yu, Ying
Bao, Ding
Huang, Yechao
Li, Xiangnan
Zhang, Yawei
Xiang, Jiaqing
Sun, Yihua
Li, Yuan
Cherniack, Andrew D. https://orcid.org/0000-0003-0470-0111
Campbell, Joshua D.
Shi, Leming
Meyerson, Matthew https://orcid.org/0000-0002-9133-8108
- License Information
-
More Information
Article History
Received: 30 November 2018
Accepted: 31 October 2019
First Online: 29 November 2019
Competing interests
: M.M. is the scientific advisory board chair of OrigiMed; an inventor of a patent licensed to LabCorp for <i>EGFR</i> mutation diagnosis; and receives research funding from Bayer. M.M. and A.M.T. receive research funding from Ono Pharmaceutical.
